Press release
Paris, 6 January 2021
Levine Keszler advises AB Science on a capital raise
AB Science has completed a capital increase (the ‘ Capital Increase ’) subscribed by
North American and European qualified investors for a total amount of approximately 15
million:
- €10.5 million raised through a private placement, without discount, at a price of €14.42 pernew ordinary
share, by means of the accelerated construction of an order book.
- This private placement involves the conversion into ordinary shares of the convertible bonds whose issue was announced on 29 October 2020 for a total amount of 4.5 million euros.
The proceeds of the Capital Increase will provide AB Science with the additional resources necessary to fund its clinical research program.
necessary to fund its clinical research programme and extends its financing horizon
beyond the next twelve months.
Levine Keszler advised AB Science on this transaction.
Counsel to AB Science:
Levine Keszler (Pierre Treille, partner, Mickaël Guillemot).
The full press release is attached.
